Animal
Model Market -Overview
The
Animal Model Market Insights by Animal Type (Pigs, Cats, and Mice),
Technology (CRISPR, Microinjection, Embryonic Stem Cell Injection), Application
(Research and Development and Production and Quality Control), End-User
(Research Institutes, Educational Institutes, Pharmaceutical Companies,
Contract Research Organizations) and Region (Americas, Europe, Asia-Pacific,
Middle East & Africa) - Forecast till 2032
Animal
Model Market Size was valued at USD 2.1 billion in 2021 and is projected to
grow from USD 2.26 billion in 2022 to USD 4.2 billion by 2032, exhibiting a
compound annual growth rate (CAGR) of 7.1% during the forecast period (2023 -
2032).
The
market is anticipated to grow due to the higher demand for precision medicine
and improved investigators' awareness of biological similarities between humans
and animals. Furthermore, the widespread adoption of genetics in biomedical
studies and steadily increasing use of animal models in pre-clinical
development by several research facilities and biopharmaceutical industries
will further enhance the market development.
Segmental
Analysis
The
segmental evaluation of the animal model market trends is carried out based on animal type,
application, end user, and application. The technology segment of the animal
model market consists of CRISPR, embryonic stem cell injection, and
microinjection. The application segment of the animal model market consists of
production & quality control and research & development. The end-user
segment of the animal model market consists of research institutes,
pharmaceutical companies, contract research organizations, and educational
institutes. The animal type segment of the animal model market consists of
cats, pigs, and mice.
Detailed
Regional Analysis
The
regional examination of the animal market is carried out for the
Americas, Asia-Pacific, Europe, Middle East & Africa. The expansion in favourable
policies implemented by the US and Canadian governments is helping to raise
various funding plans in the research and development activities, which is one
of the primary reasons for this tremendous growth. In addition, there has been
a significant increase in the number of investments coming in. As a result, the
animal model market in this region is expected to grow at the fastest rate.
Asia-Pacific offers excellent advantages for key players in the animal model
market, owing to an increment in the number of initiatives and public spending
for overall R&D of medicines using animal models and an expansion in the
implications of mouse clinical trials (MCTs) for more predicting outcomes.
Competitive
Analysis
The
ability to stay in touch with end-users while effectively expanding the
comprehensive footprint is poised to grow as the main goal for several market
stakeholders. A need to pool viable alliances is predicted to become more
apparent in the market. The market is likely to be defined by the governments'
agreed-upon measures for revitalizing the entire market. Market competition is
expected to be the driving force behind several global market growth policy
restructurings. In the projected period, changes in manufacturing and
distribution tactics are projected to augment the market on a global scale. The
transition to a more effective working environment is set to change the
established working method during the period considered. Developing a better
service delivery channel is expected to define the global market's subsequent
phase of development. The market is supposed to pick up on the impacts of the
current state of affairs presently.
The
distinguished players in the animal model market are GenOway S.A. (France),
Envigo (US), Transgenic, Inc. (Japan), Charles River Laboratories (UK), Taconic
Laboratories (UK), SAGE Labs (US), Crown Bioscience Inc. (US), Janvier Labs
(France), Harbor Antibodies Bv (A Subsidiary of Harbor BioMed) (Massachusetts)
and Horizon Discovery (England).
Industry
Updates:
Nov
2021 The Boston firm, which develops and manufactures next-generation in vitro
models that enable researchers to duplicate and study human biology and
disease, described Zo-CM2 as a "pivotal advancement." Platform
advancements broaden applicability and reliability for researchers and drug
makers through remote operation, support, and continual software updates. The
technique, aimed at industry, university academics, and government agencies,
allows professionals to comprehend better and anticipate medication reactions
than is achievable with traditional cell culture or animal-based methodologies.
About
Market Research Future:
At Market
Research Future (MRFR), we enable our customers to unravel the complexity of
various industries through our Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), & Consulting Services. MRFR team have supreme
objective to provide the optimum quality market research and intelligence
services to our clients.
Contact us:
Market Research
Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,
5Th Floor,
New York, New
York 10013
United States of
America
+1 628 258 0071
Email:
sales@marketresearchfuture.com
Comments
Post a Comment